# Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes

> **NCT07548996** · PHASE2,PHASE3 · RECRUITING · sponsor: **Nanjing Medical University** · enrollment: 96 (estimated)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Dimethyl Fumarate Enteric-coated Capsules
- **DRUG:** Insulin

## Key facts

- **NCT ID:** NCT07548996
- **Lead sponsor:** Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-27
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07548996

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07548996, "Open-Label Study of Dimethyl Fumarate in Adults With Type 1 Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07548996. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*